Bagotsay, Adela B.

HRN: 27-87-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFTRIAXONE 1G (VIAL)
09/28/2025
10/05/2025
IV
2g
Od
Tbi, Moderate
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines